000			03363cam a2200349 a 4500
003			EG-GiCUC
005			20250223032910.0
008			220108s2021 ua dho f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.21.04.Ph.D.2021.Na.E
100	0		_aNashwa Elsayed Hassan Ragab Elsherif
245	1	0	_aEffect of balance training on balance and functional activities in women treated with chemotherapy / _cNashwa Elsayed Hassan Ragab Elsherif ; Supervised Salwa Mostafa Elbadry , Abeer Mohamed Eldeeb , Lobna Rashed Ezz Elarab
246	1	5	_aتأثير تمارين الإتزان على التوازن والأنشطة الوظيفية لدى السيدات اللاتى تعالجن بالعلاج الكيميائى
260			_aCairo : _bNashwa Elsayed Hassan Ragab Elsherif , _c2021
300			_a139 P. : _bcharts , facsimiles , photoghraphs ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - Faculty of Physical Therapy - Department of Physical Therapy for Gynecology and Obstetrics
520			_aThis study was aimed to evaluate the effect of balance training program on balance, neuropathy symptoms and functional activities in cancer women whom treated with chemotherapy. A total of 40 breast cancer women complained from chemotherapy induced peripheral neuropathy (CIPN) participated in the study. Their age was 40-50 years and their body mass index (BMI) ranged from 25 to 34.9 Kg/m². They were randomly distributed into two equal groups. Both control and study groups received neurotoxic potential chemotherapy including paclitaxel and docetaxel for at least 4 cycles within the previous 6 months and continued to receive their dose as an adjuvant therapy. In addition, the study group received a balance training program for 50-60 minutes, 2 sessions/week for 12 weeks. Each patient was assessed using Biodex balance system to measure the overall stability index (OSI), anteroposterior stability index (APSI), and mediolateral stability index (MLSI). Also, the functional reach test was used to assess the functional reach distance (FRD) and chemotherapy-induced peripheral neuropathy assessment tool (CIPNAT) was used to assess neuropathy symptoms and functional activities before and after 12 weeks of the study course. Results showed that there was no significance difference in OSI (p=0.26), APSI (p=0.51), MLSI (p=0.38), functional reach distance (p=0.23), interference items score (p=0.31), and a significant increase (p=0.03) in the symptom experience items score of the control group post-treatment. However, there was a highly significant decrease (p=0.0001) in the OSI, APSI, and MLSI, interference items score, and symptom experience items score, as well as a highly significant increase (p=0.0001) in the functional reach distance of the study group post-treatment
530			_aIssued also as CD
653		4	_aBreast cancer
653		4	_aChemotherapy-Induced peripheral neuropathy
653		4	_aFunctional activities
700	0		_aAbeer Mohamed Eldeeb , _eSupervisor
700	0		_aLobna Rashed Ezz Elarab , _eSupervisor
700	0		_aSalwa Mostafa Elbadry , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aShimaa _eCataloger
942			_2ddc _cTH
999			_c83876 _d83876